Back to News
Market Impact: 0.2
Surgery Partners Consensus Price Target Increased by 15.45% to $22.61
Source: Nasdaq
Analyst InsightsAnalyst EstimatesHealthcare & Biotech
Fintel's aggregate one-year price target for Surgery Partners rose 15.45% to $22.61 per share from $19.58, the prior estimate dated October 20, 2026. The report provides no additional context or share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
SGRY0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Apple reports after the bell. Options traders expect a big move
- Why is Apple stock falling afterhours today?
- Mizuho lowers Lumentum stock price target on Marvell acquisition